Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
Results from NAPOLI 3 trial of first-line NALIRIFOX vs gemcitabine + nab-paclitaxel in mPDAC, presented at ASCO GI 2023 as reported by Clinical Care Options (CCO)
In slides from Clinical Care Options (CCO), experts provide perspectives on updates in biomarker testing and targeted therapy across GI cancers
Experts highlight key studies being presented at the upcoming 2023 ASCO GI annual meeting in this commentary from Clinical Care Options (CCO)
Expert review of key data in GI cancers from the 2022 ASCO Annual Meeting, from Clinical Care Options (CCO)
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.